EUPRAXIA PHARMACEUTICALS INC (EPRX.CA) Stock Balance Sheet
TSX:EPRX - Toronto Stock Exchange - CA29842P1053 - Common Stock - Currency: CAD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 33.10M | 19.34M | 24.74M | 20.89M | 150.00K | |||
| Cash Equivalents | N/A | 0.00 | N/A | N/A | N/A | |||
| Marketable Securities | N/A | N/A | 0.00 | 9.01M | N/A | |||
| Receivables | 228.90K | 190.60K | 120.00K | 430.00K | 620.00K | |||
| Other Current Assets | 1.11M | 270.70K | 320.00K | 270.00K | 370.00K | |||
| Total Current Assets | 34.44M | 19.80M | 25.18M | 30.60M | 1.14M | |||
| Non-Current Assets | ||||||||
| PPE Net | 424.90K | 456.30K | 700.00K | 590.00K | 320.00K | |||
| Other Non-Current Assets | 80.80K | 6.90K | 0.00 | 30.00K | N/A | |||
| Total Non-Current Assets | 505.70K | 463.10K | 700.00K | 620.00K | 310.00K | |||
| TOTAL ASSETS | 34.94M | 20.27M | 25.88M | 31.22M | 1.45M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 17.57M | |||
| Current Portion Of LT Debt. | 0.00 | 10.40M | 180.00K | 150.00K | 50.00K | |||
| Accrued Expenses | 92.60K | 71.70K | 20.00K | 10.00K | 160.00K | |||
| Accounts Payable | 3.01M | 3.87M | 3.94M | 2.11M | 3.04M | |||
| Other Current Liabilities | 0.00 | 5.04M | N/A | 0.00 | 1.72M | |||
| Total Current Liabilities | 3.10M | 19.37M | 4.14M | 2.27M | 22.54M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 10.37M | 9.40M | 200.00K | |||
| Other Non-Current Liabilities | N/A | 0.00 | N/A | 0.00 | 380.00K | |||
| Total Non-Current Liabilities | -1.57M | -1.32M | 8.88M | 8.57M | 120.00K | |||
| TOTAL LIABILITIES | 1.54M | 18.05M | 13.02M | 10.84M | 22.66M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -131.00M | -105.50M | -97.45M | -74.19M | -51.20M | |||
| Additional Paid In Capital | 20.50M | 17.51M | 17.96M | 13.86M | 6.19M | |||
| Minority Interest | -1.57M | -1.32M | -1.49M | -830.00K | -450.00K | |||
| Common Shares | 148.07M | 92.91M | 92.34M | 80.71M | 23.80M | |||
| Other Shareholders' Equity | -4.16M | -2.71M | N/A | N/A | N/A | |||
| Shares Outstanding | 35.64M | 27.28M | 21.59M | 14.24M | 12.87M | |||
| Tangible Book Value per Share | 0.05 | 0.08 | 0.60 | 1.43 | -1.65 | |||
| Total Shareholders' Equity | 33.40M | 2.22M | 12.86M | 20.39M | -21.21M | |||
| TOTAL LIABILITIES AND EQUITY | 34.94M | 20.27M | 25.88M | 31.22M | 1.45M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | 0.81 | 0.46 | -0.84 | |||
| Current Ratio | 11.10 | 1.02 | 6.08 | 13.48 | 0.05 | |||
| Return On Assets (ROA) | -72.98% | -139.25% | -89.88% | -73.64% | -275.86% | |||
| Return On Equity (ROE) | -76.34% | -1273.39% | -180.87% | -112.75% | N/A | |||
All data in USD , ROIC based on taxRate of 0.28